ArticleBMC cancer2025

Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer.

Jiahui Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.